Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Atrial Fibrillation
Trial Information
A phase II, study to assess the safety and effect on ventricular rate of multiple oral doses of study drug in adult subjects with atrial fibrillation
To evaluate the safety and effect on ventricular rate of four
escalating oral doses of study drug administered once a day in
adult subjects with atrial fibrillation and a rapid ventricular
response.
Several Study Inclusion Criteria Include:
- Be able to perform an exercise stress test on a treadmill
- Have adequate anticoagulation therapy according to the
physician
- Be 18 years of age or older
Several Study Exclusion Criteria Include:
- Atrial flutter
- Within 30 days, had an MI, acute coronary syndrome, cardiac
surgery or a CVA(stroke)
- Untreated alcoholism or drug addiction
Holy Cross Hospital Research Center
4875 N. Federal Hwy, Suite 700
Fort Lauderdale, FL 33308
Phone: 954-229-8400
Fax: 954-229-8597
View Google Map
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
